about
Imaging characteristics of pathologically proven thymic hyperplasia: identifying features that can differentiate true from lymphoid hyperplasiaSurvivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model studyMyasthenia gravis: a clinical-immunological update.Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR).Thymectomy lowers the myasthenia gravis biomarker miR-150-5p.Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Thymus pathology observed in the MGTX trial.
@en
type
label
Thymus pathology observed in the MGTX trial.
@en
prefLabel
Thymus pathology observed in the MGTX trial.
@en
P2093
P2860
P1476
Thymus pathology observed in the MGTX trial.
@en
P2093
Alexander Marx
Berthold Schalke
Frederik Pfister
Philipp Ströbel
Wilfred Nix
P2860
P304
P356
10.1111/J.1749-6632.2012.06799.X
P407
P577
2012-12-01T00:00:00Z